Plain-language summaries of peer-reviewed peptide research, protocol design notes, and compound profiles — written by our in-house research team for fellow researchers.
An orally-active growth hormone secretagogue that mimics ghrelin signalling. Here's what the current research literature says about its effects on GH/IGF-1, sleep, and body composition.
Why research cycles are typically run in 8–12 week blocks — and how researchers structure washout windows, dose timing, and stacking across a multi-compound protocol.
A look at the compounds — from Tirzepatide to AOD-9604 — that appear most often in contemporary fat loss research literature, and what the data actually suggests.
Two of the most-studied recovery peptides in research settings. We break down how their mechanisms differ, where they overlap, and why many protocols use them together.
A plain-language summary of the current BPC-157 literature — mechanism of action, tissue repair signals, and what researchers should know before designing a protocol.